参考文献/References:
[1] Riddle MC,Cefalu WT,Evans PH,et al.Consensus report:definition and interpretation of remission in type 2 diabetes[J].Diabetes Care,2021,44(10):2438-2444.DOI:10.2337/dci21-0034.
[2] 杨雪,陈国芳,刘超.逆转2型糖尿病的现状与展望[J].中华糖尿病杂志,2021,13(7):666-672.DOI:10.3760/cma.j.cn115791-20210305-00127.
[3] Kelly J,Karlsen M,Steinke G.Type 2 diabetes remission and lifestyle medicine:a position statement from the American college of lifestyle medicine[J].Am J Lifestyle Med,2020,14(4):406-419.DOI:10.1177/1559827620930962.
[4] Rickels MR,Robertson RP.Pancreatic islet transplantation in humans:recent progress and future directions[J].Endocr Rev,2019,40(2):631-668.DOI:10.1210/er.2018-00154.
[5] Marfil-Garza BA,Hefler J,Bermudez De Leon M,et al.Progress in translational regulatory T cell therapies for type 1 diabetes and islet transplantation[J].Endocr Rev,2021,42(2):198-218.DOI:10.1210/endrev/bnaa028.
[6] Atif M,Conti F,Gorochov G,et al.Regulatory T cells in solid organ transplantation[J].Clin Transl Immunology,2020,9(2):e01099.DOI:10.1002/cti2.1099.
[7] Boitard C,Yasunami R,Dardenne M,et al.T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice[J].J Exp Med,1989,169(5):1669-1680.DOI:10.1084/jem.169.5.1669.
[8] Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151-1164.
[9] Hull CM,Peakman M,Tree TIM.Regulatory T cell dysfunction in type 1 diabetes:what's broken and how can we fix it[J].Diabetologia,2017,60(10):1839-1850.DOI:10.1007/s00125-017-4377-1.
[10] Lindley S,Dayan CM,Bishop A,et al.Defective suppressor function in CD4(+)CD25(+)T-cells from patients with type 1 diabetes[J].Diabetes,2005,54(1):92-99.DOI:10.2337/diabetes.54.1.92.
[11] Glisic-Milosavljevic S,Waukau J,Jailwala P,et al.At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction[J].PLoS One,2007,2(1):e146.DOI:10.1371/journal.pone.0000146.
[12] Rickels MR,Robertson RP.Pancreatic islet transplantation in humans:recent progress and future directions[J].Endocr Rev,2019,40(2):631-668.DOI:10.1210/er.2018-00154.
[13] Pathak S,Meyer EH.Tregs and mixed chimerism as approaches for tolerance Induction in islet transplantation[J].Front Immunol,2021,11:612737.DOI:10.3389/fimmu.2020.612737.
[14] Vaikunthanathan T,Safinia N,Boardman D,et al.Regulatory T cells:tolerance induction in solid organ transplantation[J].Clin Exp Immunol,2017,189(2):197-210.DOI:10.1111/cei.12978.
[15] Graca L,Cobbold SP,Waldmann H.Identification of regulatory T cells in tolerated allografts[J].J Exp Med,2002,195(12):1641-1646.DOI:10.1084/jem.20012097.
[16] Berney T,Ferrari-Lacraz S,Bühler L,et al.Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes:over the 10-year mark[J].Am J Transplant,2009,9(2):419-23.DOI:10.1111/j.1600-6143.2008.02481.x.
[17] 张梅,徐书杭,徐瑜,等.CFSE标记抗原特异性CD4+CD25+T细胞在胰岛移植体内归巢的研究[J].细胞与分子免疫学杂志,2008,24(12):1174-1176.DOI:10.3321/j.issn:1007-8738.2008.12.013.
[18] Koprivica I,Vujicˇic' M,Gajic' D,et al.Ethyl pyruvate stimulates regulatory T cells and ameliorates type 1 diabetes development in mice[J].Front Immunol,2019,9:3130.DOI:10.3389/fimmu.2018.03130.
[19] Li Z,Shi X,Liu J,et al.Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells[J].FASEB J,2019,33(7):8241-8248.DOI:10.1096/fj.201900146R.
[20] Akimoto H,Fukuda-Kawaguchi E,Duramad O,et al.A novel liposome formulation carrying both an insulin peptide and a ligand for invariant natural killer T cells induces accumulation of regulatory T cells to islets in nonobese diabetic mice[J].J Diabetes Res,2019,2019:9430473.DOI:10.1155/2019/9430473.
[21] Mbongue JC,Rawson J,Garcia PA,et al.Reversal of new onset type 1 diabetes by oral salmonella-based combination therapy and mediated by regulatory T-cells in NOD mice[J].Front Immunol,2019,10:320.DOI:10.3389/fimmu.2019.00320.
[22] Yoon IH,Chung H,Kim HJ,et al.Peri-graft porcine-specific CD4+ FoxP3+ regulatory T cells by CD40-CD154 blockade prevented the rejection of porcine islet graft in diabetic mice[J].Xenotransplantation,2019,26(5):e12533.DOI:10.1111/xen.12533.
[23] Marek-Trzonkowska N,Mys'liwiec M,Dobyszuk A,et al.Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets-results of one year follow-up[J].Clin Immunol,2014,153(1):23-30.DOI:10.1016/j.clim.2014.03.016.
[24] Hu M,Hawthorne WJ,Nicholson L,et al.Low-dose interleukin-2 combined with rapamycin led to an expansion of CD4+CD25+FOXP3+ regulatory T Cells and prolonged human islet allograft survival in humanized mice[J].Diabetes,2020,69(8):1735-1748.DOI:10.2337/db19-0525.
相似文献/References:
[1]袁扬,孙子林.PANDER与β细胞凋亡[J].国际内分泌代谢杂志,2007,(04):253.
[2]刘媛 刘超.1型糖尿病青少年儿童心理行为问题研究进展[J].国际内分泌代谢杂志,2015,(01):63.[doi:10.3760/cma.j.issn.1673-4157.2015.01.016]
Liu Yuan,Liu Chao..Psychological problems in adolescents and children with type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):63.[doi:10.3760/cma.j.issn.1673-4157.2015.01.016]
[3]王思倩,吴锦丹.肠促胰素对1型糖尿病患者血糖及胰岛功能的影响[J].国际内分泌代谢杂志,2015,(03):196.[doi:10.3760/cma.j.issn.1673-4157.2015.03.015]
Wang Siqian,Wu Jindan..Effects of incretin on blood glucose and islet function in type 1 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(01):196.[doi:10.3760/cma.j.issn.1673-4157.2015.03.015]
[4]李亚兰,项洁,卜瑞芳.1型糖尿病的DiaPep277免疫治疗[J].国际内分泌代谢杂志,2014,(03):169.[doi:10.3760/cma.j.issn.1673-4157.2014.03.007]
Li Yalan,Xiang Jie,Bu Ruifang..Immunotherapy with DiaPep277 peptide in type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2014,(01):169.[doi:10.3760/cma.j.issn.1673-4157.2014.03.007]
[5]陈晔,李艳玲,王坚.天然免疫细胞在1型糖尿病中的作用[J].国际内分泌代谢杂志,2014,(03):184.[doi:10.3760/cma.j.issn.1673-4157.2014.03.011]
Chen Ye,Li Yanling,Wang Jian..Role of innate immune cells in type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(01):184.[doi:10.3760/cma.j.issn.1673-4157.2014.03.011]
[6]蔡芸莹 苏恒.1型糖尿病的非胰岛素治疗[J].国际内分泌代谢杂志,2015,(06):388.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.007]
Cai Yunying,Su Heng.Noninsulin management in type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):388.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.007]
[7]王静 张梅.胰高血糖素在1型糖尿病治疗中的研究进展[J].国际内分泌代谢杂志,2018,38(01):19.[doi:10.3760/cma.j.issn.1673-4157.2018.01.005]
Wang Jing,Zhang Mei.Research progress of glucagon for the treatment of type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):19.[doi:10.3760/cma.j.issn.1673-4157.2018.01.005]
[8]朱婧 蒋晓红 项守奎 许晨 华飞.1型糖尿病患者尿酸水平与血脂异常的
相关性研究[J].国际内分泌代谢杂志,2020,40(01):16.[doi:10.3760/cma.j.issn.1673-4157.2020.01.004]
Zhu Jing,Jiang Xiaohong,Xiang Shoukui,et al.Correlation between uric acid level and dyslipidemia in patients with type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2020,40(01):16.[doi:10.3760/cma.j.issn.1673-4157.2020.01.004]
[9]马金刚 魏红丽 尚恒.Graves病患者外周血T细胞亚群与甲状腺
功能及甲状腺自身抗体间的相关性分析[J].国际内分泌代谢杂志,2020,40(01):21.[doi:10.3760/cma.j.issn.1673-4157.2020.01.005]
Ma Jingang,Wei Hongli,Shang Heng.Correlation between peripheral blood T cell subsets and thyroid function and thyroid autoantibodies in patients with Graves' disease[J].International Journal of Endocrinology and Metabolism,2020,40(01):21.[doi:10.3760/cma.j.issn.1673-4157.2020.01.005]
[10]周小海,安晔,王小玲,等.1型糖尿病合并非酒精性脂肪性肝病与慢性肾脏病的关系[J].国际内分泌代谢杂志,2021,41(04):339.[doi:10.3760/cma.j.cn121383-20200713-07032]
Zhou Xiaohai,An Ye,Wang Xiaoling,et al.Relationship between nonalcoholic fatty liver disease and chronic kidney disease in patients with type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2021,41(01):339.[doi:10.3760/cma.j.cn121383-20200713-07032]